Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients

Volume: 21, Issue: 6, Pages: 1038 - 1047
Published: Sep 1, 2021
Abstract
Pancreaticoduodenal cancer (PDC) is a group of malignant tumors arising in the ampullary region, which lack approved targeted therapies for their treatment. This retrospective, observational study is based on Secondary Data Use (SDU) previously collected during a multicenter collaboration, which were subsequently entered into a predefined database and analyzed. FoundationOne CDx or Liquid, a next-generation DNA sequencing (NGS) service, was used...
Paper Details
Title
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients
Published Date
Sep 1, 2021
Volume
21
Issue
6
Pages
1038 - 1047
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.